SLU Institute for Drug and Biotherapeutic Innovation
@slu-idbi.bsky.social
The Institute for Drug and Biotherapeutic Innovation leverages faculty expertise at Saint Louis University to to discover, develop, and translate new medical therapies as part of the University’s mission to serve humanity.
October 17, 2025 at 12:20 PM
Suchir Ryali, Meghana Govindaraj, Carlos Formoso, Faranak Pooladian, Gwendalyn Krekeler, Hannah Lupton, and Clémence Gieré all took home poster awards for their presentations.
Thank you to all of the attendees, presenters, volunteers, and judges who made this event such a success! 6/6
Thank you to all of the attendees, presenters, volunteers, and judges who made this event such a success! 6/6
September 25, 2025 at 2:29 PM
Suchir Ryali, Meghana Govindaraj, Carlos Formoso, Faranak Pooladian, Gwendalyn Krekeler, Hannah Lupton, and Clémence Gieré all took home poster awards for their presentations.
Thank you to all of the attendees, presenters, volunteers, and judges who made this event such a success! 6/6
Thank you to all of the attendees, presenters, volunteers, and judges who made this event such a success! 6/6
Finally, the symposium was closed out by 70 posters presented in two sessions from our high school, undergraduate, graduate, and post-doctoral researchers. 5/6
September 25, 2025 at 2:29 PM
Finally, the symposium was closed out by 70 posters presented in two sessions from our high school, undergraduate, graduate, and post-doctoral researchers. 5/6
The final two oral presentations were from Kyle Oberkrom on the GPR183 axis in painful inflammatory conditions, and Waruna Thotamune on structure-guided protein engineering to probe GPCR signaling dynamics! 4/6
September 25, 2025 at 2:29 PM
The final two oral presentations were from Kyle Oberkrom on the GPR183 axis in painful inflammatory conditions, and Waruna Thotamune on structure-guided protein engineering to probe GPCR signaling dynamics! 4/6
We then heard five brief talks from Daphne Kim on NaV1.8 control of DRG neurons, Elora Koski on screening novel compounds against ESCAPE pathogens, Amelia Fox, Ph.D. on SIX transcription factors role in FSHD, 3/6
September 25, 2025 at 2:29 PM
We then heard five brief talks from Daphne Kim on NaV1.8 control of DRG neurons, Elora Koski on screening novel compounds against ESCAPE pathogens, Amelia Fox, Ph.D. on SIX transcription factors role in FSHD, 3/6
The symposium was led by an excellent keynote address from Cory Berkland, who discussed the influence of market and regulatory feedback on shaping research in a biotech setting (and how that feedback enables the bench to biotech transition). 2/6
September 25, 2025 at 2:29 PM
The symposium was led by an excellent keynote address from Cory Berkland, who discussed the influence of market and regulatory feedback on shaping research in a biotech setting (and how that feedback enables the bench to biotech transition). 2/6
Congratulations to all co-authors in the Salvemini and DiPaolo labs. Important work defining pain mechanisms and supporting drug repurposing and novel discovery to treat neuropathic pain.
September 17, 2025 at 8:33 PM
Congratulations to all co-authors in the Salvemini and DiPaolo labs. Important work defining pain mechanisms and supporting drug repurposing and novel discovery to treat neuropathic pain.